Terms: = Lymphoma AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
59 results:
1. Quality and Quantity of Nucleic Acids Extracted from Formalin-Fixed Paraffin-Embedded lymphoma Biopsies from Nigerian Archived Biopsy.
Uzoma IC; Taiwo IA; Ugwu NI; Durosinmi MA; Akinloye O
Niger J Clin Pract; 2023 Dec; 26(12):1854-1860. PubMed ID: 38158353
[TBL] [Abstract] [Full Text] [Related]
2. The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study.
Duan H; Gao S; Zhang L; Song L; Zhai J; Deng X
Clin Rheumatol; 2024 Jan; 43(1):561-568. PubMed ID: 37755548
[TBL] [Abstract] [Full Text] [Related]
3. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract] [Full Text] [Related]
4. Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo.
Benvenuto M; Angiolini V; Focaccetti C; Nardozi D; Palumbo C; Carrano R; Rufini A; Bei R; Miele MT; Mancini P; Barillari G; Cirone M; Ferretti E; Tundo GR; Mutti L; Masuelli L; Bei R
Biol Direct; 2023 Apr; 18(1):17. PubMed ID: 37069690
[TBL] [Abstract] [Full Text] [Related]
5. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract] [Full Text] [Related]
6. Correlation of B-cell lymphoma 2 immunoexpression in invasive carcinoma of breast, no special type with hormone receptor status, proliferation index, and molecular subtypes.
Azmat H; Faridi J; Habib HM; Bugti UJ; Sheikh AK; Riaz SK
J Cancer Res Ther; 2022 Dec; 18(Supplement):S313-S319. PubMed ID: 36510982
[TBL] [Abstract] [Full Text] [Related]
7. Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers.
Xu Y; Liang Y; Yin G
Clin Transl Oncol; 2023 Apr; 25(4):1024-1032. PubMed ID: 36376700
[TBL] [Abstract] [Full Text] [Related]
8. Investigation of the function of the PI3-Kinase / AKT signaling pathway for leukemogenesis and therapy of acute childhood lymphoblastic leukemia (ALL).
Ehm P; Grottke A; Bettin B; Jücker M
Cell Signal; 2022 May; 93():110301. PubMed ID: 35259456
[TBL] [Abstract] [Full Text] [Related]
9. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
[TBL] [Abstract] [Full Text] [Related]
10. Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience.
Riva M; Berno T; Cipriani A; Altinier S; Fedrigo M; Noventa F; Adami F
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e970-e974. PubMed ID: 34489209
[TBL] [Abstract] [Full Text] [Related]
11. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract] [Full Text] [Related]
12. Association of an anaplastic lymphoma kinase pathway signature with cell de-differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer.
Liu D; Wu Y
Cancer Commun (Lond); 2020 Sep; 40(9):422-434. PubMed ID: 32822101
[TBL] [Abstract] [Full Text] [Related]
13. Molecular profiling of non-small cell lung cancer.
Forsythe ML; Alwithenani A; Bethune D; Castonguay M; Drucker A; Flowerdew G; French D; Fris J; Greer W; Henteleff H; MacNeil M; Marignani P; Morzycki W; Plourde M; Snow S; Xu Z
PLoS One; 2020; 15(8):e0236580. PubMed ID: 32756609
[TBL] [Abstract] [Full Text] [Related]
14. Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
Yi ZB; Yu P; Zhang S; Wang WN; Han YQ; Ouyang QC; Yan M; Wang XJ; Hu XC; Jiang ZF; Huang T; Tong ZS; Wang SS; Yin YM; Li H; Yang RX; Yang HW; Teng YE; Sun T; Cai L; Li HY; Chen X; He JJ; Liu XL; Yang SE; Wang JY; Fan JH; Qiao YL; Xu BH
Int J Cancer; 2021 Feb; 148(3):692-701. PubMed ID: 32700765
[TBL] [Abstract] [Full Text] [Related]
15. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
[TBL] [Abstract] [Full Text] [Related]
16. A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring her2 Aberration in Japan (her2-CS STUDY).
Ninomiya K; Hata T; Yoshioka H; Ohashi K; Bessho A; Hosokawa S; Ishikawa N; Yamasaki M; Shibayama T; Aoe K; Kozuki T; Harita S; Ueda Y; Murakami T; Fujimoto N; Yanai H; Toyooka S; Takata M; Hotta K; Kiura K;
Chest; 2019 Aug; 156(2):357-366. PubMed ID: 31072612
[TBL] [Abstract] [Full Text] [Related]
17. Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.
Michalarea V; Fontana E; Garces AI; Williams A; Smyth EC; Picchia S; Rao S; Chau I; Cunningham D; Bali MA
Curr Probl Cancer; 2019 Oct; 43(5):487-494. PubMed ID: 30827742
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive analysis of PD-L1 expression, her2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
[TBL] [Abstract] [Full Text] [Related]
19. Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?
Athauda A; Segelov E; Ali Z; Chau I
Cancer Treat Rev; 2019 Feb; 73():31-40. PubMed ID: 30597479
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
[TBL] [Abstract] [Full Text] [Related]
[Next]
